Matthew G. Nankivell

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Transdermal Estradiol Patches in Prostate Cancer. Reply.

Transdermal Estradiol Patches in Prostate Cancer. Reply.

Journal: The New England journal of medicine

Published: July 29, 2026

The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trial.

The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 13, 2026

The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.

The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.

Journal: British journal of cancer

Published: April 02, 2026

Validation of tumour-negative lymph node size as a novel independent prognostic biomarker in oesophagogastric adenocarcinoma: post hoc analysis of the UK MRC OE05 and ST03 randomised trials.

Validation of tumour-negative lymph node size as a novel independent prognostic biomarker in oesophagogastric adenocarcinoma: post hoc analysis of the UK MRC OE05 and ST03 randomised trials.

Journal: ESMO open

Published: March 31, 2026

Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.

Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.

Journal: The New England journal of medicine

Published: March 25, 2026

The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.

The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 07, 2025

Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 29, 2025

Healthcare Systems Data (HSD) to Improve the Efficiency of Clinical Trials Within the UK: A Prospectively Planned Comparison of HSD and Trial-Reported Outcomes Within the Add-Aspirin Cancer Clinical Trial.

Healthcare Systems Data (HSD) to Improve the Efficiency of Clinical Trials Within the UK: A Prospectively Planned Comparison of HSD and Trial-Reported Outcomes Within the Add-Aspirin Cancer Clinical Trial.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: June 20, 2025

Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials.

Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials.

Journal: BMC pharmacology & toxicology

Published: June 20, 2025

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy.

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 13, 2024

Intra-patient comparison of microarchitecture of tumour negative lymph nodes from oesophageal cancer patients - Results from the MRC Oe02 trial.

Intra-patient comparison of microarchitecture of tumour negative lymph nodes from oesophageal cancer patients - Results from the MRC Oe02 trial.

Journal: Pathology, research and practice

Published: November 04, 2024

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-Inferiority.

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-Inferiority.

Journal: Statistics in medicine

Published: August 04, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026